Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis

Jens Van Loon; Jacques Bodenstein Bezuidenhout; Benedikt Engels; Guy Soete; Tim Everaert; Anne-Sophie Bom; Benjamin Valere Vanspeybroeck; Nele Platteaux; Sven Van Laere; Thierry Gevaert; Mark De Ridder

doi:10.1016/S0167-8140(24)02585-4

Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis

Jens Van Loon, Jacques Bodenstein Bezuidenhout, Benedikt Engels, Guy Soete, Tim Everaert, Anne-Sophie Bom, Benjamin Valere Vanspeybroeck, Nele Platteaux, Sven Van Laere, Thierry Gevaert, Mark De Ridder

Onderzoeksoutput: Poster

Originele taal-2	English
Pagina's	S2513-S2514
Aantal pagina's	2
DOI's	https://doi.org/10.1016/S0167-8140(24)02585-4
Status	Published - 2024
Evenement	ESTRO 2024 - Glasgow, United Kingdom Duur: 3 mei 2024 → 7 mei 2024

Conference

Conference	ESTRO 2024
Land/Regio	United Kingdom
Stad	Glasgow
Periode	3/05/24 → 7/05/24

Bibliografische nota

ESTRO 2024, 3-7 May 2024, Glasgow, UK

Toegang tot document

10.1016/S0167-8140(24)02585-4

Andere bestanden en links

https://www.sciencedirect.com/science/article/pii/S0167814024025854

Citeer dit

Van Loon, J., Bezuidenhout, J. B., Engels, B., Soete, G., Everaert, T., Bom, A.-S., Vanspeybroeck, B. V., Platteaux, N., Van Laere, S., Gevaert, T., & De Ridder, M. (2024). Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis. S2513-S2514. Postersessie gepresenteerd op ESTRO 2024, Glasgow, United Kingdom. https://doi.org/10.1016/S0167-8140(24)02585-4

@conference{32719f08474642f4a6f876759e52d0f8,

title = "Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis",

author = "{Van Loon}, Jens and Bezuidenhout, {Jacques Bodenstein} and Benedikt Engels and Guy Soete and Tim Everaert and Anne-Sophie Bom and Vanspeybroeck, {Benjamin Valere} and Nele Platteaux and {Van Laere}, Sven and Thierry Gevaert and {De Ridder}, Mark",

note = "ESTRO 2024, 3-7 May 2024, Glasgow, UK; ESTRO 2024 ; Conference date: 03-05-2024 Through 07-05-2024",

year = "2024",

doi = "10.1016/S0167-8140(24)02585-4",

language = "English",

pages = "S2513--S2514",

}

Van Loon, J, Bezuidenhout, JB, Engels, B, Soete, G , Everaert, T , Bom, A-S , Vanspeybroeck, BV , Platteaux, N , Van Laere, S , Gevaert, T & De Ridder, M 2024, 'Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis', ESTRO 2024, Glasgow, United Kingdom, 3/05/24 - 7/05/24 blz. S2513-S2514. https://doi.org/10.1016/S0167-8140(24)02585-4

TY - CONF

T1 - Phase II Study of MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days: Toxicity Analysis

AU - Van Loon, Jens

AU - Bezuidenhout, Jacques Bodenstein

AU - Engels, Benedikt

AU - Soete, Guy

AU - Everaert, Tim

AU - Bom, Anne-Sophie

AU - Vanspeybroeck, Benjamin Valere

AU - Platteaux, Nele

AU - Van Laere, Sven

AU - Gevaert, Thierry

AU - De Ridder, Mark

N1 - ESTRO 2024, 3-7 May 2024, Glasgow, UK

PY - 2024

Y1 - 2024

UR - https://www.sciencedirect.com/science/article/pii/S0167814024025854

U2 - 10.1016/S0167-8140(24)02585-4

DO - 10.1016/S0167-8140(24)02585-4

M3 - Poster

SP - S2513-S2514

T2 - ESTRO 2024

Y2 - 3 May 2024 through 7 May 2024

ER -